Company Can-Fite BioPharma Ltd.

CANF

IL0010944739

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Can-Fite BioPharma Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Biopharmaceuticals

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:15 2024-07-11 am EDT			5-day change	1st Jan Change
3.8 ^ILa	+8.57%		+22.58%	+46.15%

Jul. 01	Can-Fite BioPharma Ltd. Announces Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson	CI
Jun. 28	Can-Fite BioPharma Ltd. Announces Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Vetbiolix	CI

Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Number of employees: 8

ILS in Million	2022	Weight	2023	Weight	Delta
Biopharmaceuticals 100.0 %	3	100.0 %	3	100.0 %	+0.69%

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	3	100.0 %	3	100.0 %	+0.69%

Managers	Title	Age	Since
Motti Farbstein CEO	Chief Executive Officer	59	03-07-31
Pnina Fishman FOU	Founder	74	94-09-10
Ilan Cohn FOU	Founder	68	94-09-10
Zivit Harpaz CTO	Chief Tech/Sci/R&D Officer	-	-
Michael Silverman CTO	Chief Tech/Sci/R&D Officer	-	-
Sari Fishman PRN	Corporate Officer/Principal	52	03-12-31
William D. Kerns PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Abraham Sartani BRD	Director/Board Member	76	00-12-31
Ilan Cohn FOU	Founder	68	94-09-10
Pnina Fishman FOU	Founder	74	94-09-10
Yaacov Goldman BRD	Director/Board Member	69	17-07-31
Guy Regev BRD	Director/Board Member	55	11-06-30
Yossi Bornstein BRD	Director/Board Member	66	21-08-04

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,656,728,493	1,656,306,120 ( 99.97 %)	0	99.97 %

Name	Equities	%	Valuation
IBI Mutual Funds Management (1978) Ltd. 0.1334 %	2,210,774	0.1334 %	19 411 ILa
Alumot Sprint Mutual Funds Management Ltd. 0.0659 %	1,092,174	0.0659 %	9 589 ILa
Pnina Fishman 0.0159 %	263,433	0.0159 %	2 313 ILa
Ilan Cohn 0.008062 %	133,567	0.008062 %	1 173 ILa
Guy Regev 0.001463 %	24,240	0.001463 %	213 ILa
Motti Farbstein 0.000068 %	1,133	0.000068 %	10 ILa
Yossi Bornstein 0.000000 %	0	0.000000 %	- ILa
Sari Fishman 0.000000 %	0	0.000000 %	- ILa
Yaacov Goldman 0.000000 %	0	0.000000 %	- ILa
Abraham Sartani 0.000000 %	0	0.000000 %	- ILa

Name	Equities	%	Valuation
Armistice Capital LLC 6.932 %	382,798	6.932 %	987 619 ILa
Morgan Stanley Capital Services LLC 1.011 %	55,807	1.011 %	143 982 ILa
RhumbLine Advisers LP 0.3347 %	18,482	0.3347 %	47 684 ILa
Citadel Securities GP LLC 0.2566 %	14,171	0.2566 %	36 561 ILa
FIFTH THIRD BANCORP 0.0543 %	3,000	0.0543 %	7 740 ILa
UBS Securities LLC 0.0393 %	2,172	0.0393 %	5 604 ILa
National Bank Financial, Inc. 0.0109 %	600	0.0109 %	1 548 ILa
Citigroup Global Markets, Inc. (Investment Management) 0.0100 %	553	0.0100 %	1 427 ILa

Can-Fite BioPharma Ltd.

26 Ben Gurion Street

5257346, Ramat Gan

+972 3 924 1114

http://www.canfite.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.038

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CAN-FITE BIOPHARMA LTD.	+46.15%	17.28M
CSL LIMITED	+6.96%	98.81B
SAMSUNG BIOLOGICS CO.,LTD.	+7.24%	42.32B
BIOGEN INC.	-8.49%	34.48B
UCB	+82.57%	29.83B
BIOMARIN PHARMACEUTICAL INC.	-12.97%	15.93B
INCYTE CORPORATION	-0.80%	14.01B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.22%	11.52B
ALTEOGEN INC.	+173.60%	10.45B
SWEDISH ORPHAN BIOVITRUM AB	+4.57%	9.06B

Biopharmaceuticals